Cardioprotection by Guanxin II in rats with acute myocardial infarction is related to its three compounds

Journal of Ethnopharmacology

Volumn 121, Issue 2, 2009, Pages 268-273

  Huang, Xi ^a,d   Qin, Feng ^a   Zhang, Hong Min ^b   Xiao, Hong Bin ^c   Wang, Long Xin ^c   Zhang, Xue Ya ^d   Ren, Ping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Absorbed bioactive compounds; Apoptosis; Guanxin II; Myocardial infarction; Traditional Chinese medicine

Indexed keywords

CASPASE 3; FERULIC ACID; GUANXIN II; HERBACEOUS AGENT; HYDROXYSAFFLOR YELLOW A; PAEONIFLORIN; PROTOCATECHUALDEHYDE; TANSHINOL; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MEASUREMENT; NONHUMAN; RAT;

ADMINISTRATION, ORAL; ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; CASPASE 3; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 57949115864     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.10.029     Document Type: Article

References (28)

1. Abrams J., and Thadani U. Therapy of stable angina pectoris, the uncomplicated patient. Circulation 112 (2005) e255-e259
2. Boudina S., Laclau M.N., Tariosse L., Daret D.L., Gouverneur G.R., Bonoron-Ade S., Saks V., and Santos P.D. Alteration of mitochondrial function in a model of chronic ischemia in vivo in rat heart. American Journal of Physiology-Heart and Circulatory Physiology 282 (2002) H821-H831
3. Chen K.J. Certain progress in the treatment of coronary heart disease with traditional medicinal plants in China. American Journal of Chinese Medicine 9 (1981) 193-196
4. Chen Y.F., Kobayashi S., Chen J., Redetzke R.A., Said S., Liang Q., and Gerdes A.M. Short term triiodo-l-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats. Journal of Molecular and Cellular Cardiology 44 (2008) 180-187
5. De Smet P.A.G.M. Herbal remedies. New England Journal of Medicine 347 (2002) 2046-2056
6. Han J.Y., Fan J.Y., Horie Y., Miura S., Cui D.H., Ishii H., Hibi T., Tsuneki H., and Kimura I. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacology & Therapeutics 117 (2008) 280-295
7. Homma M., Oka K., Yamada T., Niitsuma T., Ihto H., and Takahashi N. A strategy for discovering biologically active compounds with high probability in traditional Chinese herb remedies: an application of saiboku-to in bronchial asthma. Analytical Biochemistry 202 (1992) 179-187
8. Huang X. Idea, background and significance of traditional Chinese medicine research according to bioethnopharmaceutical analyses. Zhongguo Zhong Xi Yi Jie He Za Zhi 2 (2002) 251-252 (in Chinese)
9. Huang X. A traditional Chinese medicine remedies (TCMRs) research strategy for exploring composing mechanism of TCMRs from their pharmacokinetics. Chinese Journal of Experimental and Traditional Medical Formula 8 (2002) 55-58 (in Chinese)
10. Huang X., Ma Y., Jiang Y.P., Xia T., and Ren P. The scientific evidence and prospect of pharmacokinetic hypothesis of traditional Chinese syndrome and formula. In: Chen K.J. (Ed). March of Integration of TCM and WM Towards 21st Century (1991), China Medico-Pharmaceutical Sciences & Technology Publishing House, Beijing 207-216 (in Chinese)
11. Huang X., Zang Y., Wang Y., Niu G., Wen A., and Ren P. Effects of tetramethylpyrazine phosphate and sodium ferulate alone or in combination on hemodynamics in anesthetized dog. American Journal of Chinese Medicine 24 (1996) 169-176
12. Kloner R.A. Natural and unnatural triggers of myocardial infarction. Progress in Cardiovascular Diseases 48 (2006) 285-300
13. Liu J.C., Kang J., Shao L.J., and He M. Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: experiment with isolated rat hearts. Zhonghua Yi Xue Za Zhi 86 (2006) 987-989 (in Chinese)
14. Liu Y.N., Zhou Z.M., and Chen P. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Clinical and Experimental Pharmacology and Physiology 35 (2008) 211-216
15. Nizamutdinova I.T., Jin Y.C., Kim J.S., Yean M.H., Kang S.S., Kim Y.S., Lee J.H., Seo H.G., Kim H.J., and Chang K.C. Paeonol and paeoniflorin, the main active principles of Paeonia albiflora, protect the heart from myocardial ischemia/reperfusion injury in rats. Planta Medica 74 (2008) 14-18
16. Pinkel D. The use of body surface area as a criterion of drug dosage in cancer chemotherapy. Cancer Research 18 (1958) 853-856
17. Qin F., Liu Y.X., Zhao H.W., Huang X., Ren P., and Zhu Z.Y. Chinese medicinal formula Guan-Xin-Er-Hao protects the heart against oxidative stress induced by acute ischemic myocardial injury in rats. Phytomedicine (2008) 10.1016/j.phymed.2008.08.005
18. Sonne D.P., Engstrøm T., and Treiman M. Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart. Regulatory Peptides 146 (2008) 243-249
19. Thibault H., Lafitte S., Timperley J., Tariosse L., Becher H., Roudaut R., and Santos P.D. Quantitative analysis of myocardial perfusion in rats by contrast echocardiography. Journal of the American Society of Echocardiography 18 (2005) 1321-1328
20. Tissier R., Berdeaux A., Ghaleh B., Couvreur N., Krieg T., Cohen M.V., and Downey J.M. Making the heart resistant to infarction: how can we further decrease infarct size. Frontiers in Bioscience 13 (2008) 284-301
21. Venardos K.M., Perkins A., Headrick J., and Kaye D.M. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Current Medicinal Chemistry 14 (2007) 1539-1549
22. Webster K.A. Programmed death as a therapeutic target to reduce myocardial infarction. Trends in Pharmacological Sciences 28 (2007) 492-499
23. Xu R., Huang X., Li Y., Zhang L., Wang L.L., and Cui P. Clinical observation in the treatment of coronary heart disease with angina pectoris with traditional Chinese prescription Guanxin II. Journal of Chengdu University of Traditional Chinese Medicine 24 (2001) 17-19 (in Chinese)
24. Ye G., Li Y.Z., Li Y.Y., Guo H.Z., and Guo D.A. SPE-HPLC method for the determination and pharmacokinetic studies on paeoniflorin in rat serum after oral administration of traditional Chinese medicinal preparation Guan-Xin-Er-Hao decoction. Journal of Pharmaceutical and Biomedical Analysis 33 (2003) 521-527
25. Yuan R., and Lin Y. Traditional Chinese medicine: an approach to scientific proof and clinical validation. Phrarmacology & Therapeutics 86 (2000) 191-198
26. Zeng X., He H., Yang J., Yang X., Wu L., Yu J., and Li L. Temporal effect of Guanxin No. 2 on cardiac function, blood viscosity and angiogenesis in rats after long-term occlusion of the left anterior descending coronary artery. Journal of Ethnopharmacology 118 (2008) 485-494
27. Zhao B.L., Jiang W., Zhao Y., Hou J.W., and Xin W.J. Scavenging effects of salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury. Biochemistry & Molecular Biology International 38 (1996) 1171-1182
28. Zhao J., Huang X., Tang W., Ren P., Xing Z., Tian X., Zhu Z., and Wang Y. Effect of oriental herbal prescription Guan-Xin-Er-Hao on coronary flow in healthy volunteers and antiapoptosis on myocardial ischemia-reperfusion in rat models. Phytotherapy Research 21 (2007) 926-931